Skip to main content
. 2020 Jan 29;10:1636. doi: 10.3389/fphar.2019.01636

Figure 2.

Figure 2

Total EEG power in the gamma frequency range (30–60 Hz) following the administration of acute SB-242084 (VEH+SB), chronic escitalopram (ESC+veh), and their combination (ESC+SB) in the first, second, and third h of the passive phase, during (A) active (AW) and (B) passive wakefulness (PW), (C) light (SWS-1) and (D) deep slow-wave sleep (SWS-2), (E) intermediate stage (IS), and (F) rapid eye movement sleep (REMS). Summarized EEG power data are presented as mean ± SEM (of n = 6 animals per group). *Significant post hoc results compared to the control group (VEH+veh), p < 0.05.